What is the advice regarding the use of mycophenolate in a patient with a gastric bypass?
Patients with a gastric bypass may need modified mycophenolate dosing due to altered pharmacokinetics and the potential for increased gastrointestinal side effects. Individualized therapy and close monitoring are advised due to significant inter-patient variability.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-03
- DOI
- https://doi.org/10.5281/zenodo.23912877
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00